Venner Shipley welcomes Brookes IP Read more
  • Great Britain
  • Germany
  • France
  • China
  • Souht Korea


We have a large team of attorneys working in the diverse field of chemistry with strong technical backgrounds in chemistry and sharing a keen interest in developments taking place in the chemical field. We also have a team of lawyers able to act on any legal issue arising in this field. We act for a variety of clients in the chemical field, including major international companies, SMEs, universities, and individual inventors.

Our experience covers a wide range of technical subject-matter including synthetic organic chemistry, inorganic and solid-state chemistry, pharmaceutical chemistry, agrochemistry, food technology, petrochemicals, graphene, metal organic frameworks (MOF’s), dyes, pigments, coatings, environmental chemistry, fuel cells, electronic chemistry, battery chemistry, catalysis, adhesives, lubricants, additives, detergent chemistry, and polymers.

Our attorneys are keenly aware of the high commercial and monetary value of many patents in the chemical field and we have been providing our clients with clear and concise advice for many years and have gained a reputation for providing a high-quality, client-focused service. Our clients use our patent services because we understand the technologies that underpin their business and appreciate the commercial importance of a well-managed patent portfolio in the chemical field.

Our attorneys draft chemical patent applications and prosecute them in countries around the world. We also frequently represent our clients in oppositions and appeals before the European Patent Office. We have an in-depth understanding of the more difficult areas of the law that tend to arise in chemical cases and are adept at providing our clients with the detail they need to make their way through these more complex patent problems.

  • Europe’s Leading Patent Law Firms 2022 by the Financial Times

  • Financial Time’s, Europe’s Leading Patent Law Firms 2021

  • An antidote to antibody patent confusion in Europe

  • Venner Shipley strengthens European presence with two senior hires

  • One year on – the impact of Actavis v Eli Lilly in the UK courts

  • Prestigious panel success for Venner Shipley

  • A millstone decision for milestone R&D payments